bullish
Celgene Acquisition by Bristol-Myers Squibb: A Call to Arbs
862 Views13 Jan 2019 14:01
On January 3, 2019, Bristol Myers Squibb Co (BMY US) and Celgene Corp (CELG US) announced a definitive agreement for BMY to acquire Celgene in a...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 15-minute read)
Discussions
(Paid Plans Only)
John DeMasi
US/Europe Event-Driven Analyst
Price Chart(Sign Up to Access)
- Bristol-Myers Beats the Drum for Celgene in 4Q18 Earnings Call25 Jan 2019
- Bristol Myers Squib – Reaffirming Its View on Celgene Corp25 Jan 2019
- Celgene and Bristol-Myers Squibb – Undervalued and Underappreciated18 Jan 2019
- We Are Buying This Large Cap Biotechnology Company After Trump's Election Win11 Nov 2016
x